Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model ; volume:31 ; number:7 ; day:8 ; month:6 ; year:2017 ; pages:617-624 ; date:7.2017
CNS drugs ; 31, Heft 7 (8.6.2017), 617-624, 7.2017
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Hard, Marjie L.
- Beteiligte Personen und Organisationen
-
Mills, Richard J.
Sadler, Brian M.
Wehr, Angela Y.
Weiden, Peter J.
Moltke, Lisa von
SpringerLink (Online service)
- DOI
-
10.1007/s40263-017-0447-7
- URN
-
urn:nbn:de:1111-201708035464
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hard, Marjie L.
- Mills, Richard J.
- Sadler, Brian M.
- Wehr, Angela Y.
- Weiden, Peter J.
- Moltke, Lisa von
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling
Clinical Pharmacokinetic Studies of Enzalutamide
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Acenocoumarol’s pharmacokinetic : linear or not?
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling
Clinical Pharmacokinetic Studies of Enzalutamide
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Acenocoumarol’s pharmacokinetic : linear or not?
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling
Clinical Pharmacokinetic Studies of Enzalutamide
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria